Causes, diagnosis, and treatment of central precocious puberty

AC Latronico, VN Brito, JC Carel - The lancet Diabetes & …, 2016 - thelancet.com
Central precocious puberty results from the premature activation of the hypothalamic-
pituitary-gonadal axis. It mimics physiological pubertal development, although at an …

Diagnosis and management of precocious sexual maturation: an updated review

AV Cheuiche, LG da Silveira, LCP de Paula… - European journal of …, 2021 - Springer
The classic definition of precocious sexual maturation is the development of secondary
sexual characteristics before 8 years of age in girls and before 9 years of age in boys. It is …

Use of gonadotropin-releasing hormone analogs in children: update by an international consortium

K Bangalore Krishna, JS Fuqua, AD Rogol… - Hormone research in …, 2019 - karger.com
This update, written by authors designated by multiple pediatric endocrinology societies
(see List of Participating Societies) from around the globe, concisely addresses topics …

Consensus statement on the use of gonadotropin-releasing hormone analogs in children

JC Carel, EA Eugster, A Rogol, L Ghizzoni… - …, 2009 - publications.aap.org
OBJECTIVE. Gonadotropin-releasing hormone analogs revolutionized the treatment of
central precocious puberty. However, questions remain regarding their optimal use in …

Central precocious puberty: From genetics to treatment

RS Aguirre, EA Eugster - Best Practice & Research Clinical Endocrinology …, 2018 - Elsevier
Central precocious puberty (CPP) results from early activation of the hypothalamic-pituitary-
gonadal (HPG) axis and follows the same sequence as normal puberty. While many factors …

[HTML][HTML] Central precocious puberty: revisiting the diagnosis and therapeutic management

VN Brito, AM Spinola-Castro, C Kochi… - … of endocrinology and …, 2016 - SciELO Brasil
Clinical and laboratory diagnosis and treatment of central precocious puberty (CPP) remain
challenging due to lack of standardization. The aim of this revision was to address the …

Central precocious puberty: update on diagnosis and treatment

M Chen, EA Eugster - Pediatric Drugs, 2015 - Springer
Central precocious puberty (CPP) is characterized by the same biochemical and physical
features as normally timed puberty but occurs at an abnormally early age. Most cases of …

Management of endocrine disease: long-term outcomes of the treatment of central precocious puberty

F Guaraldi, G Beccuti, D Gori… - European journal of …, 2016 - academic.oup.com
GnRH analogues (GnRHa) are the treatment of choice for central precocious puberty (CPP),
with the main objective to recover the height potential compromised by the premature fusion …

Treatment of central precocious puberty

EA Eugster - Journal of the Endocrine Society, 2019 - academic.oup.com
Long-acting analogs of GnRH (GnRHas) have been the gold-standard treatment of central
precocious puberty (CPP) worldwide and have an enviable track record of safety and …

The efficacy and safety of gonadotropin-releasing hormone analog treatment in childhood and adolescence: a single center, long-term follow-up study

MA Magiakou, D Manousaki, M Papadaki… - The Journal of …, 2010 - academic.oup.com
Objective: The objective of the study was to evaluate the long-term effect of GnRH analog
(GnRHa) treatment on final height (FH), body mass index (BMI), body composition, bone …